Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02992522
Brief Title: Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

First Submitted : December 12, 2016
First Submitted that Met QC Criteria : December 12, 2016
First Posted : December 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 30, 2019
Last Update Posted : June 3, 2019